Skip to main content
logo
Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
1.600
-0.030 (-1.84%)
At close: Oct 27, 2025, 4:00 PM EDT
1.610
+0.010 (0.63%)
Pre-market: Oct 28, 2025, 9:10 AM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
Novel Therapeutics
391.70K
Log In
Log In
Log In
Novel Therapeutics Growth
-73.93%
Log In
Log In
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
United States
391.70K
Log In
Log In
Log In
United States Growth
-73.93%
Log In
Log In
Log In